AMBRA1 inhibits the activity of c-MYC by enhancing the activity of PP2A, which inhibits the proliferation and tumorigenesis of cancer, but CIP2A plays the opposite role on PP2A to AMBRA1 (69). The gene discussed is PTPA; the disease is cancer.